Medco Energi Internasional Tbk (MEDC)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 1,480.00 |
|---|---|
| 52-week range | 1,005.00 – 2,000.00 |
| Return, 1 month / 3 months | +1.0% / +6.5% |
| Return, 1 year / 3 years | +8.6% / +10.5% |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 54.6% |
| Worst drawdown (1 year) | -47.2% |
| Average daily value traded | 78,717.32M IDR |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Medco Energi Internasional is an Indonesian energy company based in Jakarta. It explores for and produces oil and gas, with operations in Indonesia and other countries, and it also runs gas and power businesses serving industrial and utility customers. The company works across the energy chain, from upstream exploration and production through to gas distribution and electricity generation, and it is controlled by the Panigoro family.
Medco Energi Internasional Tbk trades under the code MEDC on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Medco Energi Internasional Tbk (MEDC) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 1,480.00 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 134 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.6% and over the last three months it rose 6.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 3.0% | ||
| From 52-week high | -25.8% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.5% | ||
| 6-month return | -15.6% | ||
| 12-month return, skipping the last month | 7.5% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 54.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.2% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 78,717.32M IDR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +14.7% |
|---|---|
| 1 month | +1.0% |
| 3 months | +6.5% |
| 6 months | −15.6% |
| 1 year | +8.6% |
| 3 years | +10.5% |
| 5 years | +208.9% |
Signals
| 50-day / 200-day average | 1,443.90 / 1,436.73 |
|---|---|
| Golden / death cross (60 days) | Golden, 7 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 79.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2026 | IDR 32.2520 |
| 11 Nov 2025 | IDR 28.4459 |
| 16 Jun 2025 | IDR 25.0000 |
| 14 Oct 2024 | IDR 15.7500 |
| 10 Jun 2024 | IDR 29.3220 |
| 30 Nov 2023 | IDR 15.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.